Royce & Associates LP Coherus Bio Sciences, Inc. Transaction History

Royce & Associates LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$5.69 - $10.07 $14,663 - $25,950	-2,577 Reduced 2.36%	106,700 $845,000
Q3 2022 Nov 03, 2022	SELL	$7.17 - $13.87 $89,675 - $173,472	-12,507 Reduced 10.27%	109,277 $1.05 Million
Q2 2022 Aug 04, 2022	SELL	$5.86 - $13.23 $124,015 - $279,986	-21,163 Reduced 14.8%	121,784 $882,000
Q1 2022 May 05, 2022	BUY	$10.92 - $16.41 $1.03 Million - $1.55 Million	94,318 Added 193.95%	142,947 $1.85 Million
Q4 2021 Feb 07, 2022	SELL	$15.81 - $18.99 $1.56 Million - $1.87 Million	-98,394 Reduced 66.92%	48,629 $776,000
Q3 2021 Nov 10, 2021	BUY	$12.68 - $17.79 $233,134 - $327,086	18,386 Added 14.29%	147,023 $2.36 Million
Q2 2021 Aug 06, 2021	BUY	$12.95 - $15.41 $15,073 - $17,937	1,164 Added 0.91%	128,637 $1.78 Million
Q1 2021 May 10, 2021	SELL	$14.42 - $21.39 $3.07 Million - $4.56 Million	-212,999 Reduced 62.56%	127,473 $1.86 Million
Q4 2020 Feb 08, 2021	SELL	$16.56 - $18.94 $497,495 - $568,995	-30,042 Reduced 8.11%	340,472 $5.92 Million
Q3 2020 Nov 12, 2020	BUY	$17.41 - $19.89 $259,391 - $296,341	14,899 Added 4.19%	370,514 $6.8 Million
Q2 2020 Aug 07, 2020	BUY	$14.43 - $19.16 $823,996 - $1.09 Million	57,103 Added 19.13%	355,615 $6.35 Million
Q1 2020 May 12, 2020	BUY	$11.67 - $22.53 $3.48 Million - $6.73 Million	298,512 New	298,512 $4.84 Million

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.